Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc

Bullboard Posts

Comment by JMark80on Nov 23, 2019 12:42am

40 Views

Post# 30384834

RE:RE:RE:RE:RE:RE:RE:🤡 JACKBOZO 🤡BEEN PLAYED!! LOLOLOL

Jack4000 wrote:

RickyAlex444 wrote: WINNING !!!!

Hardly. You don't know why but threw $8k into a private palcement and call it winning when nobody tells you how much they invesed.

Strange and disturbing. You need a hobby.

Penny never had $8k to invest. He says winning all the time as a positive affirmation.

Bullboard Posts

Desert Gold Ventures - A jewel for the investor?